Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dianthus Therapeutics, Inc. /DE/ | Director | Stock Option (Right to Buy) | 22K | Sep 16, 2024 | Direct | ||
Mallinckrodt plc | EVP & Chief Sci. Ofcr | Ordinary Shares | 0 | $37.50 | Jun 16, 2022 | Direct | |
Mallinckrodt plc | EVP & Chief Sci. Ofcr | Employee Share Options (Right to Buy) | 0 | Jun 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DNTH | Dianthus Therapeutics, Inc. /DE/ | Sep 16, 2024 | 1 | $0 | 4 | Sep 18, 2024 | Director |
DNTH | Dianthus Therapeutics, Inc. /DE/ | Sep 16, 2024 | 0 | $0 | 3 | Sep 18, 2024 | Director |
MNKPF | Mallinckrodt plc | Jun 16, 2022 | 7 | $0 | 4 | Jun 21, 2022 | EVP & Chief Sci. Ofcr |